Stresgenin B was isolated as an inhibitor of heat-induced heat shock protein (HSP) gene expression from a culture broth of Streptomyces sp. AS-9 by silica gel chromatography and HPLC. The molecular formula of the novel compound was determined as CnH13NO5by high resolution FAB-MSanalysis, and the structure was determined by UV, *H NMR,13C NMR, HMQC, HMBC, and NOESYspectra. Stresgenin B inhibited heat-induced luciferase reportergene expression directed by the humanhsp70B promoter in Chinese hamster ovary (CHO)cells at concentrations lower than the concentrations for inhibition of dexamethasone-induced luciferase reporter-gene expression directed by the mouse mammarytumor virus (MMTV)-LTRpromoter. The inhibition of heat-induced reporter gene expression was evident even when cells were exposed to stresgenin B only during heat stress treatment. Moreover, the compound inhibited heat-induced syntheses of hsp72/73, hsp90, and hspl lO and thereby suppressed the induction of thermotolerance. Stresgenin B showedmoderate cytotoxic activities against several neoplastic cell lines and also showed antibacterial activities against Micrococcus luteus, Bacillus subtilis and Staphylococcus aureus strains.
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Hyperthermia has been extensively studied clinically as a promising modality of cancer therapy1). However, there are still some problems to be resolved in the clinical settings, and one of the major problems is the induction of thermotolerance in tumors2). Therefore, a material which inhibits the induction of thermotolerance is expected to contribute to improving the effects of fractionated hyp erthermia.
Thermotolerance is a transient phenomenonin which cells becomeheat resistant as a result of prior or continuous exposure to hyperthermia2 '3) .
Many experiments have provided pieces of evidence which suggest the importance of hsp70 in induced thermotolerance in mammalian cells4~10).
A direct correlation between HSP-gene expression and thermotolerance in CHO cells was demonstratedll), and recent results have clarified that hsp70 is the anti-apoptotic protein which protects cells from cytotoxicity induced by heat12' 13), TNF13~15), monocytes16), oxidative stress17), chemotherapeutic agents15'18), ceramide12'13) and radiation1 7\
Only a few bioflavonoids including quercetin have been reported to inhibit the heat-induced HSP synthesis through the inhibition of mRNAinduction after the heat stress19 '20) . Quercetin also has been reported to prevent cells from acquiring thermotolerance after heat stress21\ In addition, quercetin potentiated the hyperthermia-induced cytotoxicity in HeLacells22) and enhanced the growth-inhibitory effect of hyperthermia on leukemic blast cells by enhancing leukemic cell apoptosis23).
These findings imply that a selective inhibitor of the heat-induced HSPsynthesis might improve hyperthermic cancer therapeutic efficacy.
In the screening using two assays for the human hsp70B Dexamethasone-induced MMTV-LTR Promoter-directed Luc-reporter Gene Expression (Dex-Luc expression) A CHO(PMAM-luc) cell clone stably expresses MMTV-LTR promoter-directed luciferase gene at 3-4 folds elevated levels (induced) depending on dexamethasone treatment24). The cells were cultured in 35mm plastic dishes at 37°C for 3 days (100% con fluent growth). After the culture was replaced with fresh medium,cells were incubated with a sample (less than 5%v/v) for 10minutes at 37°C. Then, dexamethasone (2^im) was added and cells Antimicrobial Activity
Antimicrobial activities (MICs) were determined using the broth dilution method. In these studies, Mueller Hinton broth medium (DIFCO) was used for bacteria, and YNPG broth mediumwas used for fungi and yeast. Bacteria were and cycloheximide (an inhibitor of protein synthesis) inhibited the HS-Luc expression. However, in the second assay in which inhibitors were added after the cells had been incubated for one hour at 37°C after heat shock exposure, cycloheximide exhibited the similar inhibition to that in the first screening assay, but actinomycin D showed muchless inhibition of the second assay compared with the first assay. Therefore, protein synthesis inhibitors were excluded by the second assay. The strain AS-9 was selected by these two screening assays.
In the third step, to determine promoter specificity of inhibition, the dose-response effect of the inhibitor was compared between two assays for HS-Luc expression and Dex-Lucexpression. The two assays were equally sensitive to the inhibition by cycloheximide (Fig. l-(a) ), but the HSLuc assay was less sensitive to actinomycin D inhibition ( Fig. l-(b) ). On the other hand, quercetin, which has been reported to inhibit selectively heat-induced expression of hsp genes19 '20) , exhibited a more potent inhibition of the HS-Luc assay compared with the Dex-Luc assay ( Fig. 1-(c) ). Thus, stresgenin B was isolated from the culture of the strain AS-9 as a preferential inhibitor of the HS-Luc expression ( Fig. l-(d) ).
Taxonomyof the Producing Strain
Strain AS-9 was isolated from a soil sample collected in Tokyo, Japan. As morphological characteristics, the aerial myceliumof the cultured strain was well branched and the top of the aerial mycelium was spiral. After growing up, it became divided and formed spiral spore chains. The size of elliptical spore was about 0.7-1.0X0:8-1.3jUm. The surface of the spore was smooth or rugose. No sclerotic granule, sporangium or zoospore was observed (Fig. 2) .
The results of cultural characteristics of the strain when grown on six media at 28°C are summarized in Table 1 .
The color of the surface of colony is indicated according to the symbols described in Color Harmony Manual26). The Table 2 . L,L-Diaminopimeric acid was observed as one of the components of the cell wall when the whole-cell hydrolysate of the strain was analyzed by cellulose thin layer chromatography. From the foregoing taxonomic characteristics, the strain AS-9 was found to belong to the Streptomyces genus, and named as Streptomyces sp. AS-9.
Culture and Isolation of Stresgenin B A stock culture of Streptomyces sp. AS-9 was inoculated into a 100-ml Sakaguchi flask containing 20ml of a medium consisting of soybean meal 1.5%, corn starch MS3600 2.0%, MgS04-7H2O 0.2% in tap water (pH 6.8 before sterilization).
The flask was incubated at 27°C for 72
hours on a reciprocal shaker (120rpm). Then, 0.75ml portions of the culture were transferred to each of ten 500- NBAas a matrix. The UV spectrum in MeOHsolution shows a maximumat 275 nm, indicating the presence of a dienone moiety. The lH NMR, 13C NMRand HMQC spectra suggest that there are one C-methyl, one 0-methyl, two oxymethine carbons, four olefinic carbons, and two carbonyl carbons as well as one quarternary replaced carbon in the molecule. The plane structure of stresgenin B was determined by the HMBCspectrum as shown in Fig. 3 . The *H and 13C NMR assignments are shown in Table 4 . The relative configuration of the molecule was also determined by the NOESYspectrum as shown in Fig. 4 .
Preferential Inhibition by Stresgenin B of HS-Luc Expression Relative to Dex-Luc Expression
As shown in Fig. l-(d) , the HS-Luc expression was more sensitive to stresgenin B inhibition than was the Dex-Luc expression. The 50% inhibition concentration (IC50) of 7.0 /jm for HS-Luc expression was 4.9 times lower than that of quercetin (34 jllm; Fig. l-(c) ). O: control, A: stresgenin B was added only during the recovery incubation, å¡: stresgenin B was added during the heat shock and the recovery incubation, à": stresgenin B was added only during the heat shock treatment. and subsequent incubation for 3.5hours at 37°C, did not decrease the number of viable cells in the heat challenge for 150 minutes, indicating thermotolerance induction by the conditioning heat-shock. On the other hand, cells exposed to stresgenin B (7.0^m) (å¡) only during the heat stress (42°C, 90 minutes) significantly decreased the number of viable cells as increasing the time of heat challenge at 44°C. This clearly shows that stresgenin B suppressed thermotolerance induction by the conditioning heat-shock treatment. The heat-shock treatment alone showed no significant growth inhibition (as seen at time 0 in Fig. 7) , and the exposure to stresgenin B (7.0^m) alone during 48 hours incubation at 37°C showed only a moderate inhibition of cell growth (61% of control; data not shown).
Inhibition of HS-Luc Expression
However, combined treatment with heat-shock and stresgenin B reduced viable cell number to 16%of control (see at time 0 in Fig. 7 ). These results indicated that 42°C hyperthermia enhanced the cell-killing activity of stresgenin B. Cytotoxicity and Antimicrobial Activity As shown in Table 5 , stresgenin B showed moderate cytotoxic activities against various neoplastic cell lines. Stresgenin B also showed antibacterial activities, but it showed no inhibitory activity against fungi and yeasts (Table 6 ).
Discussion
Wehave isolated stresgenin B from the culture broth of Streptomyces sp. AS-9 as an inhibitor of heat-induced HSP gene expression. The inhibitor was determined to be a novel low molecular weight compound with a unique chemical structure. Stresgenin B exhibited a preferential inhibition of the HS-Luc expression compared with the Dex-Luc expression, and also inhibited rather selectively heat-induced syntheses of hsp72/73, hsp90 and hspl lO in GHO cells (Fig. 6) .
Stresgenin B, actinomycin D, and cycloheximide inhibited the HS-Luc expression in the first screening assay in which cells were heat-shocked in the presence of the that of the first screening assay, but actinomycin D showed muchless inhibition of the second assay (data not shown).
Stresgenin B exhibited only a slight inhibition of Luc expression in the second assay (data not shown). Actually, stresgenin B showed strong inhibition of Luc induction even when it was present only during heat shock period, whereas it slightly inhibited when present only during the recovery incubation (Fig. 5) . These results suggest that stresgenin B inhibits heat-induction of the hsp70B promoter activity and does not significantly affect the posttranscriptional process for Luc expression.
Exposure of cells to stresgenin B only during the heat stress (42°C, 90minutes) inhibited the thermotolerance acquisition of CHO cells (Fig. 7) , as expected by its inhibition of heat induced hsp70 synthesis4'1 l\ Furthermore, combined treatment of cells with mild heat shock (42°C, 90 minutes) and exposure to stresgenin B induced a synergistic cell-killing (Fig. 7) . These activities of stresgenin B
propose the usefulness of this compound combined with hyperthermia as a modality of cancer therapy. Although the mechanism of inhibition of heat-induced HSP gene expression has not yet been identified, stresgenin B has similar biological activities to those of quercetin19~23). Stresgenin B, however, has some advantages: 1) at least 4.9 times more potent than quercetin for inhibition of heat-induced HSP promoter activation and 2) more water-soluble than quercetin.
